Genome science and health disparities: A growing success story?

Genome Medicine

Volumn 5, Issue 7, 2013, Pages

  Rotimi, Charles ^a   Shriner, Daniel ^a   Adeyemo, Adebowale ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN;

ARTICLE; CANCER SURVIVAL; CANCER THERAPY; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMICS; HEALTH DISPARITY; HEPATITIS C; INCIDENCE; KIDNEY FAILURE; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; MORTALITY; PREVALENCE; PRIORITY JOURNAL; SCIENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84880184188     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm465     Document Type: Article

References (10)

1. Sankar P, Cho MK, Condit CM, Hunt LM, Koenig B, Marshall P, Lee SS, Spicer P. Genetic research and health disparities. JAMA 2004, 291:2985-2989. 10.1001/jama.291.24.2985, 2271142, 15213210.
2. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010, 329:841-845. 10.1126/science.1193032, 2980843, 20647424.
3. Hershman D, Weinberg M, Rosner Z, Alexis K, Tiersten A, Grann VR, Troxel A, Neugut AI. Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst 2003, 95:1545-1548. 10.1093/jnci/djg073, 14559877.
4. Nalls MA, Wilson JG, Patterson NJ, Tandon A, Zmuda JM, Huntsman S, Garcia M, Hu D, Li R, Beamer BA, Patel KV, Akylbekova EL, Files JC, Hardy CL, Buxbaum SG, Taylor HA, Reich D, Harris TB, Ziv E. Admixture mapping of white blood cell count: genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies. Am J Hum Genet 2008, 82:81-87. 10.1016/j.ajhg.2007.09.003, 2253985, 18179887.
5. Shriner D, Adeyemo A, Rotimi CN. Joint ancestry and association testing in admixed individuals. PLoS Comput Biol 2011, 7:e1002325. 10.1371/journal.pcbi.1002325, 3245293, 22216000.
6. Suarez-Kurtz G, Botton MR. Pharmacogenetics of warfarin in populations of African descent. Br J Clin Pharmacol 2012, 75:334-346.
7. Limdi NA, Wadelius M, Cavallari L, Eriksson N, Crawford DC, Lee MT, Chen CH, Motsinger-Reif A, Sagreiya H, Liu N, Wu AH, Gage BF, Jorgensen A, Pirmohamed M, Shin JG, Suarez-Kurtz G, Kimmel SE, Johnson JA, Klein TE, Wagner MJ. International Warfarin Pharmacogenetics Consortium Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. Blood 2010, 115:3827-3834. 10.1182/blood-2009-12-255992, 2865873, 20203262, International Warfarin Pharmacogenetics Consortium.
8. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009, 461:399-401. 10.1038/nature08309, 19684573.
9. Yang JJ, Cheng C, Devidas M, Cao X, Fan Y, Campana D, Yang W, Neale G, Cox NJ, Scheet P, Borowitz MJ, Winick NJ, Martin PL, Willman CL, Bowman WP, Camitta BM, Carroll A, Reaman GH, Carroll WL, Loh M, Hunger SP, Pui CH, Evans WE, Relling MV. Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat Genet 2011, 43:237-241. 10.1038/ng.763, 3104508, 21297632.
10. Ramos E, Doumatey A, Elkahloun AG, Shriner D, Huang D, Chen G, Zhou J, McLeod H, Adeyemo A, Rotimi CN. Pharmacogenomics, ancestry and clinical decision making for global populations. Pharmacogenomics 2013,